Evaluation of the efficacy and safety of switching to tenofovir, emtricitabine, and rilpivirine in treatment-experienced patients

Laure Surgers; Nadia Valin; C. line Viala; Anders Boyd; Laurent Fonquernie; Pierre-Marie Girard; Laurence Morand-Joubert; Jean-Luc Meynard

doi:10.1097/QAI.0000000000000401

Evaluation of the efficacy and safety of switching to tenofovir, emtricitabine, and rilpivirine in treatment-experienced patients

Laure Surgers^*
, Nadia Valin
, C. line Viala
, Anders Boyd
, Laurent Fonquernie
, Pierre-Marie Girard
, Laurence Morand-Joubert
, Jean-Luc Meynard

^*Corresponding author for this work

Assistance publique – Hôpitaux de Paris
Sorbonne Université
PEPITES teams, Pierre Louis Institute for Epidemiology and Public Health, Inserm UMR 1136, Paris, France

Research output: Contribution to journal › Comment/Letter to the editor › Academic

4 Downloads (Pure)

Original language	English
Pages (from-to)	e10-e12
Journal	Journal of acquired immune deficiency syndromes (1999)
Volume	68
Issue number	1
DOIs	https://doi.org/10.1097/QAI.0000000000000401
Publication status	Published - 1 Jan 2015
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Adenine/administration & dosage
Adult
Aged
Anti-HIV Agents/administration & dosage
Deoxycytidine/administration & dosage
Drug Therapy, Combination
Emtricitabine
Female
HIV Infections/drug therapy
Humans
Male
Middle Aged
Nitriles/administration & dosage
Organophosphonates/administration & dosage
Pyrimidines/administration & dosage
Rilpivirine
Tenofovir
Young Adult

Access to Document

10.1097/QAI.0000000000000401

Evaluation-of-the-efficacy-and-safety-of-switching-to-tenofovir-emtricitabine-and-rilpivirine-in-treatment-experienced.pdfFinal published version, 101 KBLicence: Taverne

Cite this

Surgers, L., Valin, N., Viala, C. L., Boyd, A., Fonquernie, L., Girard, P.-M., Morand-Joubert, L., & Meynard, J.-L. (2015). Evaluation of the efficacy and safety of switching to tenofovir, emtricitabine, and rilpivirine in treatment-experienced patients. Journal of acquired immune deficiency syndromes (1999), 68(1), e10-e12. https://doi.org/10.1097/QAI.0000000000000401

@article{3ffd43f84df046479771700bfcc3fa76,

title = "Evaluation of the efficacy and safety of switching to tenofovir, emtricitabine, and rilpivirine in treatment-experienced patients",

keywords = "Adenine/administration \& dosage, Adult, Aged, Anti-HIV Agents/administration \& dosage, Deoxycytidine/administration \& dosage, Drug Therapy, Combination, Emtricitabine, Female, HIV Infections/drug therapy, Humans, Male, Middle Aged, Nitriles/administration \& dosage, Organophosphonates/administration \& dosage, Pyrimidines/administration \& dosage, Rilpivirine, Tenofovir, Young Adult",

author = "Laure Surgers and Nadia Valin and Viala, \{C. line\} and Anders Boyd and Laurent Fonquernie and Pierre-Marie Girard and Laurence Morand-Joubert and Jean-Luc Meynard",

year = "2015",

month = jan,

day = "1",

doi = "10.1097/QAI.0000000000000401",

language = "English",

volume = "68",

pages = "e10--e12",

journal = "Journal of acquired immune deficiency syndromes (1999)",

issn = "1525-4135",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

Surgers, L, Valin, N, Viala, CL, Boyd, A, Fonquernie, L, Girard, P-M, Morand-Joubert, L & Meynard, J-L 2015, 'Evaluation of the efficacy and safety of switching to tenofovir, emtricitabine, and rilpivirine in treatment-experienced patients', Journal of acquired immune deficiency syndromes (1999), vol. 68, no. 1, pp. e10-e12. https://doi.org/10.1097/QAI.0000000000000401

Evaluation of the efficacy and safety of switching to tenofovir, emtricitabine, and rilpivirine in treatment-experienced patients. / Surgers, Laure; Valin, Nadia; Viala, C. line et al.
In: Journal of acquired immune deficiency syndromes (1999), Vol. 68, No. 1, 01.01.2015, p. e10-e12.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Evaluation of the efficacy and safety of switching to tenofovir, emtricitabine, and rilpivirine in treatment-experienced patients

AU - Surgers, Laure

AU - Valin, Nadia

AU - Viala, C. line

AU - Boyd, Anders

AU - Fonquernie, Laurent

AU - Girard, Pierre-Marie

AU - Morand-Joubert, Laurence

AU - Meynard, Jean-Luc

PY - 2015/1/1

Y1 - 2015/1/1

KW - Adenine/administration & dosage

KW - Adult

KW - Aged

KW - Anti-HIV Agents/administration & dosage

KW - Deoxycytidine/administration & dosage

KW - Drug Therapy, Combination

KW - Emtricitabine

KW - Female

KW - HIV Infections/drug therapy

KW - Humans

KW - Male

KW - Middle Aged

KW - Nitriles/administration & dosage

KW - Organophosphonates/administration & dosage

KW - Pyrimidines/administration & dosage

KW - Rilpivirine

KW - Tenofovir

KW - Young Adult

UR - https://www.scopus.com/pages/publications/84919360209

UR - https://www.ncbi.nlm.nih.gov/pubmed/25321178

U2 - 10.1097/QAI.0000000000000401

DO - 10.1097/QAI.0000000000000401

M3 - Comment/Letter to the editor

C2 - 25321178

SN - 1525-4135

VL - 68

SP - e10-e12

JO - Journal of acquired immune deficiency syndromes (1999)

JF - Journal of acquired immune deficiency syndromes (1999)

IS - 1

ER -

Evaluation of the efficacy and safety of switching to tenofovir, emtricitabine, and rilpivirine in treatment-experienced patients

UN SDGs

Keywords

Access to Document

Other files and links

Cite this